3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Influenza, Human
13
Neoplasms
6
Colorectal Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Recurrence
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Virus Diseases
1
Vaccine-Preventable Diseases
1
Vaccination Hesitancy
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Patient Acceptance of Health Care
1
Ovarian Neoplasms
1
Osteosarcoma
1
Interventions
Tea
2
Bupivacaine
2
Tadalafil
1
Morphine
1
Lidocaine
1
Ketamine
1
Injections, Subcutaneous
1
Influenza Vaccines
1
Ethanol
1
Dexmedetomidine
1
Anesthetics, Local
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Abdominal Cancer
×
Influenza Vaccines
×
Clear all
NCT02998736
2022-12-28
PERIOP-04
Ottawa Hospital Research Institute
Phase 1
Completed
28 enrolled